Don't consider buying MARKSANS now, it is risky at the moment
02 Jul, 20255 min read
MARKSANS underperformed today. On a longer term basis, investors in MARKSANS PHARMA LIMITED made +0.03% per day. Wednesday's performance of -0.44% was a significant underperformance compared to it's daily average.